William O’Neill, MD: Minimally invasive replacement of the aortic valve
William O’Neill, MD, interventional cardiologist and investigator for the PARTNER trial, just released online in the New England Journal of Medicine, discusses this landmark trial investigating...
View ArticleJon Resar, MD: The PARTNER B trial
Interviewed by Steven Greer, MD httpv://www.youtube.com/watch?v=1G3VAQzI5Gw Dr. Jon Resar, Cath Lab Director for Johns Hopkins, discusses the PARTNER B cohort trial data and what this means for the...
View ArticleThomas Brott, MD: Review of the CREST trial of carotid stenting
The CREST trial, published earlier this year, was the latest large-scale, randomized, controlled trial to test the safety and efficacy of carotid artery stenting versus standard open CEA surgery....
View ArticleASCO preview: new breast cancer therapies
Sra Hurvitz, MD of the UCLA Jonsson Cancer Center discusses her Roche T-DM1 “Super Herceptin” presentation of the phase 3 EMILIA data.
View ArticleDaily aspirin for prevention of death from MI unwarranted in most people
Interviewed by Steven Greer, MD For decades, doctors have recommended daily aspiring to prevent death from myocardial infarction to patients with certain risk factors other than previous MI (i.e....
View ArticleHemorrhagic Complications Associated With Aspirin
Best viewed in full screen mode July 23, 2012 By Steven Greer, MD An article in the June, 2012, JAMA reported the findings of a large meta-analysis of the use of daily aspirin for primary prevention of...
View ArticleGordon Guyatt, MD: Does coffee reduce mortality?
In full screen 1080i HD for better viewing of the data graphics and NBC’s egregious coverage
View ArticleASCO 2012 preview: new therapies for melanoma
Dr. Sara Hurvitz and Dr. Antoni Ribas of the UCLA Jonsson Cancer Center preview the new melanoma therapies to be presented at the 2012 ASCO meeting.
View ArticleThe false epidemic of autism
Update March 20 , 2013 The annual CDC autism report is out again, misleading the public about a non-epidemic. Update March 29, 2012 The high prevalence of “autism” was in the news again with a CDC...
View ArticleThe Yale led reanalysis of the BMP-2 InFuse trials
Interviewed by Steven E. Greer, MD Medtronic granted rare access to a team led my Yale’s Harlan Krumholz and turned over the complete datasets on 17 InFuse (BMP-2) clinical trials. The goal was to...
View Article
